Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: SANOFI VACCINES US INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2025-09-05 to 2028-09-04
Current total value of award: $24873330
Description: TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS